References
The End of Alzheimer’s Program – Dale E. Bredesen, M.D. References
Following is a list of references from the book, The End of Alzheimer’s Program, published by Avery/Random House. Due to the length of the text, these references could not be included in the print version, and therefore are listed below.
1 – Richard E. Kennedy et al., JAMA Network Open 1, no. 7, 1–10, e184080, November 2018
Association of Concomitant Use of Cholinesterase Inhibitors or Memantine with Cognitive Decline in Alzheimer Clinical Trials: A Meta-Analysis
2 – Do Young Kim et al., PloS One 10, no. 4, e0119316, April 2015
Ketones Prevent Oxidative Impairment of Hippocampal Synaptic Integrity Through KATP Channels
2 – Leif Hertz, Ye Chen, and Helle S. Waagepetersen, Journal of Neurochemistry 134, no. 1, 7–20, July 2015
Effects of Ketone Bodies in Alzheimer’s Disease in Relation to Neural Hypometabolism, β-Amyloid Toxicity, and Astrocyte Function
3 – Roger J. Mullins et al., Human Brain Mapping 38, no. 4, 1933–40, April 2017
Exosomal Biomarkers of Brain Insulin Resistance Associated with Regional Atrophy in Alzheimer’s Disease
4 – Eric M. Reiman et al., Proceedings of the National Academy of Sciences of the United States of America 101, no. 1, 284–89, January 2004
Functional Brain Abnormalities in Young Adults at Genetic Risk for Late-Onset Alzheimer’s Dementia
5 – Stephen Cunnane et al., Nutrition 27, no. 1, 3–20, January 2011
Brain Fuel Metabolism, Aging, and Alzheimer’s Disease
6 – Marjorie Hecht, Healthline, February 15, 2018
Ketosis vs. Ketoacidosis: What You Should Know
7 – Sheila Innis, Advances in Nutrition 2, no. 3, 275–83, May 2011
Dietary Triacylglycerol Structure and Its Role in Infant Nutrition
7 – José M. Medina and Arantxa Tabernero, Journal of Neuroscience Research 79, no. 1–2, 1–15, January 2005
Lactate Utilization by Brain Cells and Its Role in CNS Development
7 – Emily Deans, Psychology Today, April 18, 2011